Metabolic dysfunction and obesity‐related cancer: Beyond obesity and metabolic syndrome
Prasoona Karra(University of Utah), Mary C. Playdon(University of Utah), Svenja Pauleck(Huntsman Cancer Institute), Cornelia M. Ulrich(University of Utah), Sheetal Hardikar(University of Utah), Maci Winn(University of Utah), Adriana M. Coletta(University of Utah), Lacie Peterson(University of Utah), Marc J. Gunter(Harvard University), Jennifer A. Doherty(Cancer Prevention Institute of California), Alicja Bulsiewicz‐Jacobsen(Huntsman Cancer Institute), Scott A. Summers(Colorado State University)
Cited by 159
Related Papers
Potential of fecal microbiota for early‐stage detection of colorectal cancer
|Molecular Systems Biology|2014|1.4k
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
|Nature Medicine|2019|1.4k
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
|Nature Medicine|2019|1.1k
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice
|Journal of Clinical Investigation|2011|680